Pahl, Heike L., 1966-
Pahl, H. L. (Heike L)
Heike L. Pahl researcher
VIAF ID: 5133165628847742480007 ( Personal )
Permalink: http://viaf.org/viaf/5133165628847742480007
Preferred Forms
- 100 0 _ ‡a Heike L. Pahl ‡c researcher
- 100 1 _ ‡a Pahl, H. L. ‡q (Heike L)
- 100 1 _ ‡a Pahl, Heike L. ‡d 1966-
- 100 1 _ ‡a Pahl, Heike L. ‡d 1966-
-
4xx's: Alternate Name Forms (10)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Biologische Effekte der NF-E2 Überexpression in hämatopoietischen Stammzellen | |
Characterization of a mouse model overexpressing transcription factor NF-E2 = Characterisierung eines Maus Modell mit einer Überexpression von NF-E2 | |
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma | |
Charakterisierung der Lymphom-initiierenden Zellpopulation und Analyse von CD30 als kritische Zielstruktur des systemischen großzellig anaplastischen Lymphoms | |
cross marks the spot: the emerging role of JmjC domain-containing proteins in myeloid malignancies | |
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis | |
hen or the egg: inflammatory aspects of murine MPN models | |
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo | |
histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells | |
Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice | |
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry | |
LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone | |
Molecular basis of chronic myeloproliferative disorders, 2004: | |
Myeloproliferative neoplasms: cause, mechanism and treatment | |
New C3H KitN824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance | |
Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling | |
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2 | |
Pharmacological inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) alone or in combination with ruxolitinib shows therapeutic efficacy in preclinical myeloproliferative neoplasm models | |
Polycythaemia vera: Retrospektive Analyse klinischer und molekularer Parameter bei einer Kohorte von 131 Patienten | |
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial | |
role of histone demathylase JMJD1C in the pathophysiology of myeloproliferative neoplasms | |
role of Jmjd1c in murine embryonic development | |
Signaltransduktion durch den Transkriptionsfaktor [NF Kappa B] | |
Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese myeloproliferativer Erkrankungen in vivo | |
Untersuchung der Zellzyklus-abhängigen Regulation des proapoptotischen Proteins Bim | |
Water pipe smoking as a cause of secondary erythrocytosis |